×
Thursday, October 2, 2025

Author

NewsService

News Service

Salarius Pharmaceuticals Announces Pause in New Patient Enrollment in its Phase 1/2 Trial of Seclidemstat in Ewing Sarcoma and FET-Rearranged Sarcomas

Tue, Oct 18, 2022 09:30 ET

Navitas Showcases Pure-Play, Next-Gen Power Semiconductors at Electronica 2022

Tue, Oct 18, 2022 09:30 ET

Eterna Therapeutics to Present at iPSC-Derived Immunotherapies Congress

Tue, Oct 18, 2022 09:30 ET

SteraMist to be Used in a Global Influenza Vaccine Facility in Australia

Tue, Oct 18, 2022 09:30 ET

Leading Electrical Distributor Sparks Up Revenue with Bridgeline’s TruPresence and Hawksearch

Tue, Oct 18, 2022 09:30 ET

BELCO COMMUNITY CREDIT UNION MARKS INTERNATIONAL CREDIT UNION DAY® WITH FINANCIAL EDUCATION PROGRAM FOR HIGH SCHOOL STUDENTS

Tue, Oct 18, 2022 09:30 ET

Xometry to Announce Third Quarter 2022 Financial Results on Nov. 10, 2022

Tue, Oct 18, 2022 09:30 ET

Getaround and KAYAK Enter Strategic Partnership, Bring Contactless Carsharing To Travelers

Tue, Oct 18, 2022 09:30 ET

Arcadis IBI Group Awarded Tri-State Traveler Information System Contract

Tue, Oct 18, 2022 09:30 ET

Recce Pharmaceuticals Announces Preclinical SARS-CoV-2 Study Update

Tue, Oct 18, 2022 09:30 ET

Parsec Capital Acquisitions Corp. Announces Execution of Merger Agreement with Enteractive Media Inc.

Tue, Oct 18, 2022 09:30 ET

CVR Energy to Release Third Quarter Earnings Results

Tue, Oct 18, 2022 09:30 ET
© SubmitMyPR All Rights Reserved 2012 - 2025